MedPath

Naproxen Codeine in Arthroscopic Surgery

Phase 4
Completed
Conditions
Arthroscopic Meniscus Surgery
Registration Number
NCT01952652
Lead Sponsor
Baskent University
Brief Summary

In this study, the aim is to compare the efficacy of single dose naproxen sodium and combination of naproxen sodium-codeine phosphate on post-operative pain in adult patients undergoing arthroscopic menisectomy.Pre-emptive oral naproxen-codeine may be safely and more advantageous than naproxen alone.

Detailed Description

Patients receiving preemptive oral naproxen sodium (Group N) or naproxen sodium-codeine phosphate (Group NC) were assigned in 2 groups.Preoperatively, drugs were given orally by a nurse unaware of the study to both groups within 60 minutes before surgery. Hemodynamic datas, possible side effects, pain and sedation levels of patients were recorded. Patient's pain and sedation levels were statistically assessed.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
61
Inclusion Criteria
  • Patients undergoing arthroscopic meniscectomy were included in the study.
Exclusion Criteria
  • ≤ 18 years of age
  • hypersensitivity to non-steroidal anti-inflammatory drugs and codeine,
  • history of peptic ulcer, gastritis, upper gastrointestinal bleeding
  • coagulation disorder
  • serious hepatic and renal impairment
  • pregnancy
  • long-term NSAID and opioid use

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Pain scores as measured by Visual Analogue Scale were significantly lower in Group Naproxen codeine (group NC) at all time points compared to Group Naproxen (group N) in 61 patients who underwent arthroscopic meniscus surgery.postoperative 18 hours

patients will be followed postoperatively 18 hours for pain levels

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Baskent University School of Medicine Adana Teaching and Research Hospital

🇹🇷

Adana, Turkey

© Copyright 2025. All Rights Reserved by MedPath